Goldin+Senneby
Spot Price, Tysabri (Biogen), 42.22mm
Spot Price, Tysabri (Biogen), 42.22mm is Goldin+Senneby’s first NFT collaboration. The work articulates the image-bias of a diagnosis of Multiple Sclerosis (MS), a degenerative autoimmune disease that Jakob Senneby was diagnosed with in the early 2000s. The work consists of three distinct sets, each consisting of a group of MRIs taken of Jakob Senneby’s brain, where white spots indicate areas of inflammation due to MS. The smart contract for the NFT, written by developer Alberto Granzotto, links the price of these images to the current (and changing) cost of three different corporate pharmaceutical drugs that Senneby has been prescribed over the years to mitigate the effects of MS. The extended essay that accompanies this NFT drop is titled Regions of Interest (ROI), borrowing a phrase from an MS researcher, but the acronym refers not just to the white spots, but also to the corporate profiteering (ROI also means return on investment) involved in the pharmaceutical industry. Since 2015, the price of FDA approved MS drugs has increased six-fold without any clear reason, and despite a US government-led investigation. This NFT project combines various conceptual associations, contemporary culture’s over-reliance on image, alongside narrative myths around certain pharma brands and marketing strategies, and the ‘making visible’ of the system and culture of illness, and the need to better understand treatment by those who have a disease.